Molly Stevens

Professor Dame Molly Stevens is John Black Professor of Bionanoscience at the University of Oxford, and also holds part-time professorships at Imperial College London and the Karolinska Institute.

Her multidisciplinary research balances the investigation of fundamental science with the development of technology to address some of the major healthcare challenges. She is a serial entrepreneur and the founder of several companies in the diagnostics, advanced therapeutics and regenerative medicine space. Her work has been instrumental in elucidating biomaterial interfaces, and she has created a broad portfolio of designer biomaterials for applications in disease diagnostics and regenerative medicine. Her substantial body of work influences research groups around the world, with over 500 publications, an h-index of 132, over 68,000 citations, and recognition as a Clarivate Analytics Highly Cited Researcher.

She holds numerous leadership positions, including Deputy Director of the Kavli Institute for Nanoscience Discovery and the UK Quantum Biomedical Sensing Research Hub, and Scientist Trustee of the National Gallery. She is a Fellow of the Royal Society, the Royal Academy of Engineering and the Academy of Medical Sciences (UK), a Foreign Member of the National Academy of Engineering (USA), and an International Honorary Member of the American Academy of Arts and Sciences. She has been recognised with over 40 international awards, including the 2023 Novo Nordisk Prize.